Patent Issued for Formulations and methods related to eye irritation (USPTO 12115147).

A patent has been issued for formulations and methods related to eye irritation by Lebrun Labs LLC. The patent focuses on developing non-animal testing methods to replace the controversial Draize test, which involves testing substances on New Zealand White rabbits. The patent introduces an in vitro method for predicting ocular irritancy of a test substance using an antioxidant formulation to reduce false positives in ocular irritation testing. The method aims to address the need for accurate and internationally accepted non-animal tests for ocular irritation. [Extracted from the article]